(R)-2-((tert-Butoxycarbonyl)amino)hex-5-enoic acid

95%

Reagent Code: #231308
fingerprint
CAS Number 219819-76-8

science Other reagents with same CAS 219819-76-8

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 229.27 g/mol
Formula C₁₁H₁₉NO₄
badge Registry Numbers
MDL Number MFCD11505911
inventory_2 Storage & Handling
Storage 2-8°C, dry

description Product Description

Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of peptide-based drugs. Its Boc-protected amine group and free carboxylic acid enable selective coupling reactions, making it valuable in solid-phase peptide synthesis. The terminal alkene group allows further modification via reactions such as olefin metathesis or hydroboration, facilitating the introduction of structural diversity in drug candidates. Commonly employed in the preparation of enzyme inhibitors and bioactive molecules where stereochemistry is critical for activity.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 100mg
10-20 days ฿10,030.00
inventory 250mg
10-20 days ฿15,150.00
inventory 1g
10-20 days ฿30,290.00
inventory 5g
10-20 days ฿68,750.00
(R)-2-((tert-Butoxycarbonyl)amino)hex-5-enoic acid
No image available

Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of peptide-based drugs. Its Boc-protected amine group and free carboxylic acid enable selective coupling reactions, making it valuable in solid-phase peptide synthesis. The terminal alkene group allows further modification via reactions such as olefin metathesis or hydroboration, facilitating the introduction of structural diversity in drug candidates. Commonly employed in the preparation of enzyme inhibi

Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of peptide-based drugs. Its Boc-protected amine group and free carboxylic acid enable selective coupling reactions, making it valuable in solid-phase peptide synthesis. The terminal alkene group allows further modification via reactions such as olefin metathesis or hydroboration, facilitating the introduction of structural diversity in drug candidates. Commonly employed in the preparation of enzyme inhibitors and bioactive molecules where stereochemistry is critical for activity.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...